Corient Private Wealth LP Invests $1.26 Million in Chemed Corporation $CHE

Corient Private Wealth LP purchased a new stake in shares of Chemed Corporation (NYSE:CHE) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 2,704 shares of the company’s stock, valued at approximately $1,259,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Geneos Wealth Management Inc. boosted its stake in Chemed by 330.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after purchasing an additional 76 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Chemed by 67.0% during the second quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company’s stock valued at $5,534,000 after purchasing an additional 4,560 shares in the last quarter. Marshall Wace LLP purchased a new stake in shares of Chemed during the second quarter valued at $579,000. Brown Advisory Inc. increased its holdings in Chemed by 36.9% in the 2nd quarter. Brown Advisory Inc. now owns 549 shares of the company’s stock worth $267,000 after buying an additional 148 shares in the last quarter. Finally, Cerity Partners LLC increased its holdings in Chemed by 237.7% in the 2nd quarter. Cerity Partners LLC now owns 4,451 shares of the company’s stock worth $2,165,000 after buying an additional 3,133 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Insider Buying and Selling

In related news, Director Patrick Grace sold 190 shares of Chemed stock in a transaction on Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the transaction, the director directly owned 3,533 shares in the company, valued at approximately $1,879,556. The trade was a 5.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Kevin McNamara sold 2,000 shares of the business’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $539.51, for a total value of $1,079,020.00. Following the sale, the chief executive officer directly owned 70,418 shares of the company’s stock, valued at $37,991,215.18. This represents a 2.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 6,537 shares of company stock valued at $3,406,014 in the last 90 days. 3.33% of the stock is owned by company insiders.

Chemed Price Performance

Shares of NYSE:CHE opened at $520.82 on Friday. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $6.81 billion, a PE ratio of 26.16, a price-to-earnings-growth ratio of 1.99 and a beta of 0.51. The firm’s 50 day moving average price is $516.70 and its 200-day moving average price is $451.82. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $557.00.

Chemed (NYSE:CHE) last announced its earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. The business had revenue of $673.25 million during the quarter, compared to analysts’ expectations of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The firm’s revenue was up 8.8% on a year-over-year basis. During the same period in the prior year, the company earned $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities research analysts expect that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 3rd. Investors of record on Monday, August 17th were issued a $0.70 dividend. The ex-dividend date of this dividend was Monday, August 17th. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. This is an increase from Chemed’s previous quarterly dividend of $0.60. Chemed’s payout ratio is 14.06%.

Analysts Set New Price Targets

Several research firms have issued reports on CHE. Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Oppenheimer increased their price objective on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research report on Friday, July 31st. Royal Bank Of Canada raised their target price on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a report on Thursday, July 30th. Finally, Bank of America reiterated a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $530.75.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.